查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1936939

全球過敏免疫療法市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Allergy Immunotherapy Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 159 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計到 2034 年，過敏免疫療法的市場規模將從 2025 年的 20.5 億美元成長至 45.7 億美元，2026 年至 2034 年的複合年成長率為 9.28%。

隨著全球過敏性疾病盛行率持續上升，過敏免疫療法市場預計將迎來顯著成長。人們對免疫療法在過敏管理中長期益處的認知不斷提高，推動了患者和醫療服務提供者對這種治療方案的興趣日益濃厚。免疫療法技術的進步，例如皮下和舌下給藥，正在推動市場發展，與傳統過敏治療方法相比，這些技術更有效、更方便。隨著對過敏反應潛在機制研究的不斷深入，標靶治療的開發有望進一步提高治療效果和患者依從性。

技術創新在塑造過敏免疫療法市場的未來前景方面發揮著至關重要的作用。個人化醫療方法（即根據個別患者情況客製化治療方案）的整合正在不斷推進。這種向精準醫療的轉變有望改善治療效果、減少副作用並提高患者滿意度。此外，生物製藥和單株抗體的出現正在改變過敏治療的格局，為治療嚴重過敏反應和慢性疾病開闢了新的途徑。隨著這些先進治療方法獲得監管部門的核准，其應用預計將加速，進一步推動市場成長。

此外，過敏免疫療法市場也受惠於預防醫學和早期療育策略日益受到重視。隨著醫療保健系統優先採用積極主動的過敏管理方法，對免疫療法的需求預計將會增加。旨在讓患者了解免疫療法益處的公共宣傳宣傳活動和教育舉措也將促進市場擴張。總之，在技術進步、個人化治療方案以及旨在改善患者療效的合作努力的推動下，過敏免疫療法市場有望顯著成長。

目錄

第1章 引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場問題
  • 波特五力分析
  • PESTLE分析

第4章 全球過敏免疫療法市場：依治療類型分類

  • 市場分析、洞察與預測
  • 皮下免疫療法
  • 舌下免疫療法

第5章：全球過敏免疫療法市場：按類型分類

  • 市場分析、洞察與預測
  • 藥片
  • 降低

第6章 全球過敏免疫療法市場：依過敏類型分類

  • 市場分析、洞察與預測
  • 過敏性鼻炎
  • 過敏性氣喘
  • 其他

第7章 全球過敏免疫療法市場：依通路分類

  • 市場分析、洞察與預測
  • 醫院藥房
  • 零售藥房
  • 網路藥房

第8章 全球過敏免疫療法市場：按地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第9章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第10章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • DMK Pharmaceuticals
    • ALK-AbellAfA3 A/S
    • Allergy Therapeutics
    • ASIT Biotech
    • Circassia
    • DVB Technologies SA
    • DESENTUM OY
    • HAL Allergy BV
    • HollisterStier Allergy
    • LETIPharma
簡介目錄
Product Code: VMR11213853

The Allergy Immunotherapy Market size is expected to reach USD 4.57 Billion in 2034 from USD 2.05 Billion (2025) growing at a CAGR of 9.28% during 2026-2034.

The allergy immunotherapy market is set for remarkable growth as the prevalence of allergic conditions continues to rise globally. With increasing awareness of the long-term benefits of immunotherapy in managing allergies, patients and healthcare providers are increasingly turning to this treatment option. The market is being driven by advancements in immunotherapy techniques, including subcutaneous and sublingual methods, which offer more effective and patient-friendly alternatives to traditional allergy treatments. As research continues to unveil the underlying mechanisms of allergic responses, the development of targeted therapies is expected to enhance treatment efficacy and patient compliance.

Technological innovations are playing a crucial role in shaping the future of the allergy immunotherapy market. The integration of personalized medicine approaches, where treatments are tailored to individual patient profiles, is gaining traction. This shift towards precision medicine is expected to improve treatment outcomes and minimize adverse effects, thereby increasing patient satisfaction. Additionally, the emergence of biologics and monoclonal antibodies is revolutionizing the landscape of allergy treatment, providing new avenues for managing severe allergic reactions and chronic conditions. As these advanced therapies gain regulatory approval, their adoption is likely to accelerate, further propelling market growth.

Furthermore, the allergy immunotherapy market is benefiting from a growing emphasis on preventive healthcare and early intervention strategies. As healthcare systems prioritize proactive approaches to managing allergies, the demand for immunotherapy is expected to rise. Public awareness campaigns and educational initiatives aimed at informing patients about the benefits of immunotherapy will also contribute to market expansion. In summary, the allergy immunotherapy market is poised for significant growth, driven by technological advancements, personalized treatment approaches, and a collective commitment to improving patient outcomes.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Treatment Type

  • Subcutaneous Immunotherapy
  • Sublingual Immunotherapy

By Type

  • Tablets
  • Drops

By Allergy Type

  • Allergic Rhinitis
  • Allergic Asthma
  • Others

By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

COMPANIES PROFILED

  • DMK Pharmaceuticals, ALKAbell AS, Allergy Therapeutics, ASIT Biotech, Circassia, DVB Technologies SA, DESENTUM OY, HAL Allergy BV, HollisterStier Allergy, LETIPharma

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL ALLERGY IMMUNOTHERAPY MARKET: BY TREATMENT TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Treatment Type
  • 4.2. Subcutaneous Immunotherapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Sublingual Immunotherapy Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ALLERGY IMMUNOTHERAPY MARKET: BY TYPE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Type
  • 5.2. Tablets Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Drops Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ALLERGY IMMUNOTHERAPY MARKET: BY ALLERGY TYPE 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Allergy Type
  • 6.2. Allergic Rhinitis Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Allergic Asthma Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ALLERGY IMMUNOTHERAPY MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast Distribution Channel
  • 7.2. Hospital Pharmacy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Retail Pharmacy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Online Pharmacy Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL ALLERGY IMMUNOTHERAPY MARKET: BY REGION 2022-2034(USD MN)

  • 8.1. Regional Outlook
  • 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.2.1 By Treatment Type
    • 8.2.2 By Type
    • 8.2.3 By Allergy Type
    • 8.2.4 By Distribution Channel
    • 8.2.5 United States
    • 8.2.6 Canada
    • 8.2.7 Mexico
  • 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.3.1 By Treatment Type
    • 8.3.2 By Type
    • 8.3.3 By Allergy Type
    • 8.3.4 By Distribution Channel
    • 8.3.5 United Kingdom
    • 8.3.6 France
    • 8.3.7 Germany
    • 8.3.8 Italy
    • 8.3.9 Russia
    • 8.3.10 Rest Of Europe
  • 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.4.1 By Treatment Type
    • 8.4.2 By Type
    • 8.4.3 By Allergy Type
    • 8.4.4 By Distribution Channel
    • 8.4.5 India
    • 8.4.6 Japan
    • 8.4.7 South Korea
    • 8.4.8 Australia
    • 8.4.9 South East Asia
    • 8.4.10 Rest Of Asia Pacific
  • 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.5.1 By Treatment Type
    • 8.5.2 By Type
    • 8.5.3 By Allergy Type
    • 8.5.4 By Distribution Channel
    • 8.5.5 Brazil
    • 8.5.6 Argentina
    • 8.5.7 Peru
    • 8.5.8 Chile
    • 8.5.9 South East Asia
    • 8.5.10 Rest of Latin America
  • 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.6.1 By Treatment Type
    • 8.6.2 By Type
    • 8.6.3 By Allergy Type
    • 8.6.4 By Distribution Channel
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE
    • 8.6.7 Israel
    • 8.6.8 South Africa
    • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

  • 9.1. Recent Developments
  • 9.2. Company Categorization
  • 9.3. Supply Chain & Channel Partners (based on availability)
  • 9.4. Market Share & Positioning Analysis (based on availability)
  • 9.5. Vendor Landscape (based on availability)
  • 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL ALLERGY IMMUNOTHERAPY INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1 DMK Pharmaceuticals
    • 10.2.2 ALK-AbellAfA3 A/S
    • 10.2.3 Allergy Therapeutics
    • 10.2.4 ASIT Biotech
    • 10.2.5 Circassia
    • 10.2.6 DVB Technologies SA
    • 10.2.7 DESENTUM OY
    • 10.2.8 HAL Allergy B.V
    • 10.2.9 HollisterStier Allergy
    • 10.2.10 LETIPharma